Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G. Guilbaud N, et al. Among authors: burbridge m. Cancer Chemother Pharmacol. 1996;38(6):513-21. doi: 10.1007/s002800050520. Cancer Chemother Pharmacol. 1996. PMID: 8823492
Experimental antitumour activity of S 16020-2 in a panel of human tumours.
Kraus-Berthier L, Guilbaud N, Jan M, Saint-Dizier D, Rouillon MH, Burbridge MF, Pierré A, Atassi G. Kraus-Berthier L, et al. Among authors: burbridge mf. Eur J Cancer. 1997 Oct;33(11):1881-7. doi: 10.1016/s0959-8049(97)00232-3. Eur J Cancer. 1997. PMID: 9470851
Antitumor activity of S 16020-2 in two orthotopic models of lung cancer.
Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Pierré A, Atassi G. Guilbaud N, et al. Among authors: burbridge m. Anticancer Drugs. 1997 Mar;8(3):276-82. doi: 10.1097/00001813-199703000-00009. Anticancer Drugs. 1997. PMID: 9095333
Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
Perron-Sierra FM, Pierré A, Burbridge M, Guilbaud N. Perron-Sierra FM, et al. Among authors: burbridge m. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1463-6. doi: 10.1016/s0960-894x(02)00197-x. Bioorg Med Chem Lett. 2002. PMID: 12031320
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab.
Burbridge MF, Bossard CJ, Saunier C, Fejes I, Bruno A, Léonce S, Ferry G, Da Violante G, Bouzom F, Cattan V, Jacquet-Bescond A, Comoglio PM, Lockhart BP, Boutin JA, Cordi A, Ortuno JC, Pierré A, Hickman JA, Cruzalegui FH, Depil S. Burbridge MF, et al. Mol Cancer Ther. 2013 Sep;12(9):1749-62. doi: 10.1158/1535-7163.MCT-13-0075. Epub 2013 Jun 26. Mol Cancer Ther. 2013. PMID: 23804704
Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells.
Sancier F, Dumont A, Sirvent A, Paquay de Plater L, Edmonds T, David G, Jan M, de Montrion C, Cogé F, Léonce S, Burbridge M, Bruno A, Boutin JA, Lockhart B, Roche S, Cruzalegui F. Sancier F, et al. Among authors: burbridge m. PLoS One. 2011 Feb 24;6(2):e17237. doi: 10.1371/journal.pone.0017237. PLoS One. 2011. PMID: 21390316 Free PMC article.
69 results